Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02176902 · ClinicalTrials.gov registry record · NA
Low-Fat Diet and Fish Oil in Men on Active Surveillance for Prostate Cancer
A NA study of Adenocarcinoma of the Prostate and Stage I Prostate Cancer, sponsored by Jonsson Comprehensive Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 107
- Enrollment target
- 1
- Study location
NCT02176902: Active NA study of Adenocarcinoma of the Prostate and Stage I Prostate Cancer, sponsored by Jonsson Comprehensive Cancer Center.
NCT02176902 is a NA study of Adenocarcinoma of the Prostate and Stage I Prostate Cancer that is active but no longer recruiting, run by Jonsson Comprehensive Cancer Center. The registered enrollment target is 107 participants, roughly in line with the 104-participant average among 21 other Adenocarcinoma of the Prostate trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02176902, a NA study of Adenocarcinoma of the Prostate and Stage I Prostate Cancer, is active but no longer recruiting, sponsored by Jonsson Comprehensive Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 107 participants
- Enrollment target
- 1
- Study location
Study Summary
This randomized phase II trial will evaluate if a low omega-6, high omega-3 fat diet combined with fish oil has the potential to delay disease progression in patients with prostate cancer undergoing active surveillance.
Primary Outcome
The primary statistical analysis will be to compare the Ki67 index between the two intervention arms using a negative binomial mixed effects model
Conditions Studied
Interventions
- OTHER laboratory biomarker analysis
- BEHAVIORAL behavioral dietary intervention
- DIETARY_SUPPLEMENT omega-3 fatty acid
Study Locations (1)
California
- Jonsson Comprehensive Cancer Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2014-11-01 |
| Est. Completion | 2026-11-01 |
| Phase | NA |
What the registry record for NCT02176902 still lists
NCT02176902 is an interventional study that assigns participants to a tested intervention. The registered 107 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 104-participant average among 21 other Adenocarcinoma of the Prostate trials with a reported enrollment target.
The record links to 4 conditions, with Adenocarcinoma of the Prostate appearing as the primary indexed condition, and to 3 interventions - of which laboratory biomarker analysis is the first listed.
NCT02176902 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02176902 about?
NCT02176902 is a clinical study titled "Low-Fat Diet and Fish Oil in Men on Active Surveillance for Prostate Cancer". This randomized phase II trial will evaluate if a low omega-6, high omega-3 fat diet combined with fish oil has the potential to delay disease progression in patients with prostate cancer undergoing active surveillance.
What is the current status of trial NCT02176902?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 107 participants. The study started on 2014-11-01. Estimated completion is 2026-11-01.
What conditions does trial NCT02176902 study?
This clinical trial studies the following conditions: Adenocarcinoma of the Prostate, Stage I Prostate Cancer, Stage IIB Prostate Cancer, Stage IIA Prostate Cancer.
What interventions are being tested in trial NCT02176902?
The interventions under investigation include: laboratory biomarker analysis (OTHER), behavioral dietary intervention (BEHAVIORAL), omega-3 fatty acid (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02176902?
This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02176902 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Adenocarcinoma of the Prostate
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02176902's enrollment target sits among peer trials
107 4th of 21 higher than 18 of 21 other Adenocarcinoma of the Prostate trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Adenocarcinoma of the Prostate trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stereotactic Body Radiation Therapy in Treating Patients With Localized High-Risk Prostate Cancer
ACTIVE NOT RECRUITING · NA
-
Diffusion-Weighted MRI in Staging Patients With Localized Prostate Cancer
COMPLETED · NA
-
Single Photon Emission Computed Tomography (SPECT) Lymph Node Mapping
COMPLETED · NA
-
Intraoperative Dosimetry for Prostate Brachytherapy Using Fluoroscopy and Ultrasound
COMPLETED · NA
-
Pilot Study of 18F-DCFPyL PET/CT in the Evaluation of Men With an Elevated PSA Following Radical Prostatectomy
COMPLETED · NA
-
Dose-Escalated Proton Radiation Therapy for High-Risk Prostate Cancer
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05491668 · 107 participants
Physiological Assessment of Severe Coronary Stenosis for Informing Planned PCI
- NCT06041594 · 107 participants · NA
Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)
- NCT06081426 · 107 participants · NA
Examining Neurobiological Mechanisms Underlying the Therapeutic Effect of the Ketogenic Diet in Bipolar Disorder (BD)
- NCT06527599 · 107 participants · NA
Screening in Trauma for Opioid Misuse Prevention - an Adaptive Intervention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI